Gene · 445
Papers3,531
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,531
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nonlinear changes in delayed functional network topology in Alzheimer's disease: relationship with amyloid and tau pathology. | Alzheimers Res Ther | 2023 | 37328909 | PubTator, text mining | PubMed |
| Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease. | Cancer Cell | 2023 | 37311413 | PubTator, text mining | PubMed |
| Elucidating the cell metabolic heterogeneity during hematopoietic lineage differentiation based on Met-Flow. | Int Immunopharmacol | 2023 | 37311353 | PubTator, text mining | PubMed |
| Chinese genetic variation database of inborn errors of metabolism: a systematic review of published variants in 13 genes. | Orphanet J Rare Dis | 2023 | 37308883 | PubTator, text mining | PubMed |
Proteomic analysis identifies argininosuccinate synthetase 1 and special AT-rich sequence binding protein 1 as reliable markers for the immunohistochemical distinction between WHO types A and B3 thymomas. | Histopathology | 2023 | 37308176 | PubTator, text mining | PubMed |
| Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage? | Int J Mol Sci | 2023 | 37298116 | PubTator, text mining | PubMed |
| Glioblastoma Metabolism: Insights and Therapeutic Strategies. | Int J Mol Sci | 2023 | 37298093 | PubTator, text mining | PubMed |
| Strategies for Reducing Toxicity and Enhancing Efficacy of Chimeric Antigen Receptor T Cell Therapy in Hematological Malignancies. | Int J Mol Sci | 2023 | 37298069 | PubTator, text mining | PubMed |
| Pathways Related to Colon Inflammation Are Associated with Colorectal Carcinoma: A Transcriptome- and Methylome-Wide Study. | Cancers (Basel) | 2023 | 37296884 | PubTator, text mining | PubMed |
| Arginine depletion attenuates renal cystogenesis in tuberous sclerosis complex model. | Cell Rep Med | 2023 | 37290438 | PubTator, text mining | PubMed |
| ATF4 renders human T-cell acute lymphoblastic leukemia cell resistance to FGFR1 inhibitors through amino acid metabolic reprogramming. | Acta Pharmacol Sin | 2023 | 37280363 | PubTator, text mining | PubMed |
| Crosstalk between arginine, glutamine, and the branched chain amino acid metabolism in the tumor microenvironment. | Front Oncol | 2023 | 37274280 | PubTator, text mining | PubMed |
| Defects in intratumoral arginine metabolism attenuate the replication and therapeutic efficacy of oncolytic myxoma virus. | J Immunother Cancer | 2023 | 37270180 | PubTator, text mining | PubMed |
| Loss of the mitochondrial protein Abcb10 results in altered arginine metabolism in MEL and K562 cells and nutrient stress signaling through ATF4. | J Biol Chem | 2023 | 37269954 | PubTator, text mining | PubMed |
| Elevated expression of histone deacetylase HDAC8 suppresses arginine-proline metabolism in necrotizing enterocolitis. | iScience | 2023 | 37260741 | PubTator, text mining | PubMed |
| A metabolic map of the DNA damage response identifies PRDX1 in the control of nuclear ROS scavenging and aspartate availability. | Mol Syst Biol | 2023 | 37259925 | PubTator, text mining | PubMed |
| Pancreatic tumors exhibit myeloid-driven amino acid stress and upregulate arginine biosynthesis. | Elife | 2023 | 37254839 | PubTator, text mining | PubMed |
| Polymorphic Variants of ASS1 Gene Related to Arginine Metabolism and the Risk of HCC. | Protein Pept Lett | 2023 | 37254538 | PubTator, text mining | PubMed |
| Dynamic polarization of tumor-associated macrophages and their interaction with intratumoral T cells in an inflamed tumor microenvironment: from mechanistic insights to therapeutic opportunities. | Front Immunol | 2023 | 37251409 | PubTator, text mining | PubMed |
| Therapeutic and diagnostic applications of exosomal circRNAs in breast cancer. | Funct Integr Genomics | 2023 | 37243750 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/445/papers?page=20